Drug Approval | May 07, 2026
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Approval strengthens the company’s growing international anti-infective portfolio
Approval strengthens the company’s growing international anti-infective portfolio
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Muted movement reflects consolidation phase as investors await earnings triggers
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
In his new role, Karthik will lead human capital strategy and HR operations across these regions
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Subscribe To Our Newsletter & Stay Updated
